title: Poly (ADP-ribose) polymerase (PARP) inhibitors for the treatment of advanced germline BRCA2 mutant prostate cancer.
authors.forename: S K
authors.initials: SK
authors.lastname: Sandhu
authors.forename: A
authors.initials: A
authors.lastname: Omlin
authors.forename: L
authors.initials: L
authors.lastname: Hylands
authors.forename: S
authors.initials: S
authors.lastname: Miranda
authors.forename: L J
authors.initials: LJ
authors.lastname: Barber
authors.forename: R
authors.initials: R
authors.lastname: Riisnaes
authors.forename: A H
authors.initials: AH
authors.lastname: Reid
authors.forename: G
authors.initials: G
authors.lastname: Attard
authors.forename: L
authors.initials: L
authors.lastname: Chen
authors.forename: I
authors.initials: I
authors.lastname: Kozarewa
authors.forename: H
authors.initials: H
authors.lastname: Gevensleben
authors.forename: J
authors.initials: J
authors.lastname: Campbell
authors.forename: K
authors.initials: K
authors.lastname: Fenwick
authors.forename: I
authors.initials: I
authors.lastname: Assiotis
authors.forename: D
authors.initials: D
authors.lastname: Olmos
authors.forename: T A
authors.initials: TA
authors.lastname: Yap
authors.forename: P
authors.initials: P
authors.lastname: Fong
authors.forename: N
authors.initials: N
authors.lastname: Tunariu
authors.forename: D
authors.initials: D
authors.lastname: Koh
authors.forename: L R
authors.initials: LR
authors.lastname: Molife
authors.forename: S
authors.initials: S
authors.lastname: Kaye
authors.forename: C J
authors.initials: CJ
authors.lastname: Lord
authors.forename: A
authors.initials: A
authors.lastname: Ashworth
authors.forename: J
authors.initials: J
authors.lastname: de Bono
mesh_terms: D000368:Aged; D000736:Androstenes; D000737:Androstenols / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D024682:BRCA2 Protein / Q000235:genetics*; D001859:Bone Neoplasms / Q000556:secondary; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation; D060787:Neoplasm Grading; D010793:Phthalazines / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000235:genetics*
chemical_list: D000736:Androstenes; D000737:Androstenols; D000970:Antineoplastic Agents; D024682:BRCA2 Protein; C551750:BRCA2 protein, human; D010793:Phthalazines; D010879:Piperazines; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; C089740:abiraterone; C531550:olaparib